References
- Bartlett JG. Clostridium difficile: History of its role as an enteric pathogen and the current state of knowledge about the organism. Clin Infect Dis. 1994;18(suppl 4):S265–S272.
- Hall IC, O’Toole E: Intestinal flora in newborn infants with a description of a new pathogenic anaerobe, Bacillus difficilis, Am J Dis Child, 1935, vol. 49 (pg. 390-402)
- Smith LDS, King EO. Occurrence of Clostridium difficile in infections of man, J Bacteriol, 1962, vol. 84 (pg. 65-7)
- Green RH. The association of viral activation with penicillin toxicity in guinea pigs and hamsters, Yale J Biol Med, 1974, vol. 47 (pg. 166-81)
- Tedesco FJ, Barton RW, Alpers DH. Clindamycin-associated colitis: a prospective study, Ann Intern Med, 1974, vol. 81 (pg. 429-33)
- Larson HE, Price AB, Honour P, Borriello SP. Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet. 1978 May 20;1(8073):1063-6. doi: 10.1016/s0140-6736(78)90912-1. PMID: 77366.
- Paul A. Lawson, Diane M. Citron, Kerin L. Tyrrell, Sydney M. Finegold, Reclassification of Clostridium difficile as Clostridioides difficile. Anaerobe, Volume 40, 2016, Pages 95-99, ISSN 1075-9964
- Editorial: C difficile- a rose by any other name. The Lancet Infectious Disease. 2019 May. Volume 19, Issue 5, p449
- McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short - stay hospitals. Emerg Infect Dis. 2006;12:409–415.
- Cohen SH, Gerding DN, Johnson S: Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)Infect Control Hosp Epidemiol201031543145520307191
- Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: New developments in epidemiology and pathogenesis. Nature Reviews Microbiology. 2009;7:526–536.
- CDC- 2019 Annual Report for the Emerging Infections Program for Clostridioides difficile Infection
- Guh AY et al: Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes. N Engl J Med 2020;382:1320-1330
- Finn, E., Andersson, F.L. & Madin-Warburton, M. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI. BMC Infect Dis 21, 456 (2021).
- Zimlichman E, Henderson D, Tamir O, et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med 2013; 173: 2039–2046.
- Buddle JE, Fagan RP. Pathogenicity and virulence of Clostridioides difficile. Virulence. 2023 Dec;14(1):2150452. doi: 10.1080/21505594.2022.2150452. PMID: 36419222; PMCID: PMC9815241
- Warny M, Pepin J, Fang A: Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005; 36694911079108416182895
- Goorhuis A, Bakker D, Corver J: Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 2008; 4791162117018808358
- Smith AB, Soto Ocana J, Zackular JP 2020. From Nursery to Nursing Home: Emerging Concepts in Clostridioides difficile Pathogenesis. Infect Immun 88:10.1128/iai.00934-19.
- Schwartz O et al: Characterization of community-acquired Clostridioides difficile strains in Israel, 2020–2022. Front. Microbiol., 19 December 2023. Sec. Infectious Agents and Disease. Volume 14 - 2023
- Juneau C, Mendias EN, Wagal N, Loeffelholz M, Savidge T, Croisant S, Dann S. Community-Acquired Clostridium Difficile Infection: Awareness and Clinical Implications. J Nurse Pract. 2013 Jan;9(1):1-6. doi: 10.1016/j.nurpra.2012.10.007. PMID: 23814528; PMCID: PMC3694783.
- Ogielska M et al: Emergence of community-acquired Clostridium difficile infection: the experience of a French hospital and review of the literature. International Journal of Infectious Diseases, Volume 37, 2015, Pages 36-41. ISSN 1201-9712,
- Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RL, Donskey CJ: Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis 2007; 45899299817879913
- Fu Y, Luo Y, Grinspan AM. Epidemiology of community-acquired and recurrent Clostridioides difficile infection. Therapeutic Advances in Gastroenterology. 2021;14. doi:10.1177/17562848211016248
- Al Saif N, Brazier JS. The distribution of Clostridium difficile in the environment of South Wales. J Med Microbiol. 1996;45(2):133–7.
- Marsh JW. Counterpoint: is Clostridium difficile a food-borne disease? Anaerobe. 2013;21:62–3.
- Thornton, C.S., Rubin, J.E., Greninger, A.L. et al. Epidemiological and genomic characterization of community-acquired Clostridium difficile infections. BMC Infect Dis 18, 443 (2018). https://doi.org/10.1186/s12879-018-3337-9